Miami Womens Interagency HIV Study WIHS

迈阿密妇女机构间艾滋病毒研究 WIHS

基本信息

项目摘要

DESCRIPTION (provided by applicant): A growing proportion of U.S. women with HIV infection are from the Southeastern United States. Compared to all other states in the Southern region of the U.S., Florida has the highest number of HIV-infected individuals and the highest rates of HIV transmission. Miami-Dade County has one of the highest rates of new infections among women and the prevalence of HIV among women was among the highest in a national study of 21 epicenter cities in the U.S. Heterosexual transmission and intravenous drug use were the major risk factors for infection. Compounding these issues, Miami-Dade County ranks high among U.S. areas in measures of social and economic distress. The Women's Interagency HIV Study (WIHS) seeks to expand its efforts to better understand the current epidemiology of HIV infection in women with the identification of new sites from the Southern region of the U.S. The Miami WIHS is well positioned to engage women with HIV infection and at risk for HIV infection that are representative of this region and the changing demographics of the HIV epidemic, as well as addressing important current treatment outcomes and the impact of disassociation from care among hard-to-reach populations (e.g. substance abusing individuals). Miami sits at the portal to the Caribbean and Central and South America and, as a result of the high rates of immigration from these regions; the women infected with HIV belong to a wide, diverse population. In addition, the HIV-infected population of women in Miami spans generational boundaries from pediatrics through to the elder. This project is a multiple PI project between the University of Miami Miller School of Medicine and the Columbia University Mailman School of Public Health with collaboration from the University of Florida. We will seek to enroll a diverse cohort of 300 youth, young adult and adult women, including women who are at-risk for HIV, those with limited disease progression, those with newly recognized infection, who are antiretroviral treatment na¿ve and antiretroviral treatment experienced participants, and who are in care, intermittently in care and not in care. A highly experienced and diverse team of researchers has been assembled to ensure the success of this program, including clinical, basic and behavioral/social scientists, with strong ties to th community. The specific aims outlined respond directly to the overall WIHS scientific goals and advance and expand the WIHS basic, clinical and epidemiologic/behavioral/social science research agenda. The proposed scientific agenda taps into the experience and expertise of the Miami WIHS researchers to examine critically important and scientifically rigorous research questions. The proposed research projects will examine the impact of aging on immune functionality; reproductive decision making among young adult and adult women living with HIV/AIDS; increasing viral diversity and the impact of HIV-1 non-B subtype infections on the clinical course of HIV and response to therapy; and the interplay of crack cocaine use and associated co-occurring epidemics (mental health, poverty, unemployment and interpersonal violence with uptake of optimal antiretroviral therapy and engagement and retention in care. By coupling the diverse population base of HIV-infected and at risk women with the recognized strengths in HIV/AIDS research, the Miami WIHS is perfectly situated to advance the overall WIHS scientific agenda of defining clinical outcomes among women across their lifespan, including the uptake of antiretroviral therapy; use and retention of HIV primary care and other ancillary services; treatment outcomes on viral suppression, immune recovery and normalization of the effects of HIV, and disease pathogenesis, as well as, promoting and advancing local scientific research goals.
描述(由申请人提供):越来越多的感染HIV的美国女性来自美国东南部。与美国南部地区的所有其他州相比,佛罗里达州感染艾滋病毒的人数最多,艾滋病毒传播率最高。迈阿密-戴德县是女性新感染率最高的县之一,在一项针对美国21个中心城市的全国性研究中,女性艾滋病毒感染率是最高的。异性恋传播和静脉注射毒品是感染的主要危险因素。使这些问题更加复杂的是,迈阿密-戴德县在美国的社会和经济困境指标中名列前茅。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Margaret A Fischl其他文献

Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT
  • DOI:
    10.1186/1742-6405-5-5
  • 发表时间:
    2008-03-28
  • 期刊:
  • 影响因子:
    2.500
  • 作者:
    Kimberly Y Smith;Winkler G Weinberg;Edwin DeJesus;Margaret A Fischl;Qiming Liao;Lisa L Ross;Gary E Pakes;Keith A Pappa;CTracey Lancaster
  • 通讯作者:
    CTracey Lancaster

Margaret A Fischl的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Margaret A Fischl', 18)}}的其他基金

Miami Womens Interagency HIV Study WIHS
迈阿密妇女机构间艾滋病毒研究 WIHS
  • 批准号:
    8432758
  • 财政年份:
    2013
  • 资助金额:
    $ 169.21万
  • 项目类别:
Miami Womens Interagency HIV Study WIHS
迈阿密妇女机构间艾滋病毒研究 WIHS
  • 批准号:
    8787709
  • 财政年份:
    2013
  • 资助金额:
    $ 169.21万
  • 项目类别:
Miami HIV/AIDS Clinical Therapeutic and Vaccine Trial Unit
迈阿密艾滋病毒/艾滋病临床治疗和疫苗试验中心
  • 批准号:
    8130215
  • 财政年份:
    2010
  • 资助金额:
    $ 169.21万
  • 项目类别:
Clinical Sciences
临床科学
  • 批准号:
    7667255
  • 财政年份:
    2008
  • 资助金额:
    $ 169.21万
  • 项目类别:
Clinical Sciences Core Research Plan (C)
临床科学核心研究计划(C)
  • 批准号:
    8465179
  • 财政年份:
    2007
  • 资助金额:
    $ 169.21万
  • 项目类别:
Clinical Sciences Core Research Plan (C)
临床科学核心研究计划(C)
  • 批准号:
    8675789
  • 财政年份:
    2007
  • 资助金额:
    $ 169.21万
  • 项目类别:
Miami Treatment and Prevention Clinical Trials Unit (CTU)
迈阿密治疗和预防临床试验中心 (CTU)
  • 批准号:
    8784167
  • 财政年份:
    2007
  • 资助金额:
    $ 169.21万
  • 项目类别:
Miami HIV/AIDS Clinical Therapeutic and Vaccine Trial Unit
迈阿密艾滋病毒/艾滋病临床治疗和疫苗试验中心
  • 批准号:
    7565979
  • 财政年份:
    2007
  • 资助金额:
    $ 169.21万
  • 项目类别:
Miami HIV/AIDS Clinical Therapeutic and Vaccine Trial Unit
迈阿密艾滋病毒/艾滋病临床治疗和疫苗试验中心
  • 批准号:
    7354845
  • 财政年份:
    2007
  • 资助金额:
    $ 169.21万
  • 项目类别:
Miami HIV/AIDS Clinical Therapeutic and Vaccine Trial Unit
迈阿密艾滋病毒/艾滋病临床治疗和疫苗试验中心
  • 批准号:
    8010176
  • 财政年份:
    2007
  • 资助金额:
    $ 169.21万
  • 项目类别:

相似海外基金

Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 169.21万
  • 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
  • 批准号:
    10738120
  • 财政年份:
    2023
  • 资助金额:
    $ 169.21万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10526768
  • 财政年份:
    2022
  • 资助金额:
    $ 169.21万
  • 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
  • 批准号:
    10701072
  • 财政年份:
    2022
  • 资助金额:
    $ 169.21万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10679092
  • 财政年份:
    2021
  • 资助金额:
    $ 169.21万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10432133
  • 财政年份:
    2021
  • 资助金额:
    $ 169.21万
  • 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
  • 批准号:
    10327065
  • 财政年份:
    2021
  • 资助金额:
    $ 169.21万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10377366
  • 财政年份:
    2019
  • 资助金额:
    $ 169.21万
  • 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
  • 批准号:
    10574496
  • 财政年份:
    2019
  • 资助金额:
    $ 169.21万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 169.21万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了